Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma
Patients with low LA and positive EBV DNA correlated with poorer 5-year PFS and OS.
»
12/09/23
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in Manitoba.
Radiographic response to first-line HER2-directed therapy predictor for LTS.
»
12/04/23
A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
DeepRP-RC achieved high performance in predicting pathological complete response.
»
12/07/23
Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response.
Anoikis patterns play important roles in tumor immunity.
»
04/03/23
Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study
Patients who received RT demonstratedlower cumulative incidence of distant metastasis.
»
12/08/23
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.
DRP-104 treated CRPC cells rescued by addition of nucleosides.
»
11/07/23
Harnessing p53 to improve immunotherapy for lung cancer treatment.
Decreased cGAS/STING signaling may explain possible resistance to ICB.
»
12/12/23
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Potent molecular and immunological effects of BRAFi/MEKi in sensitive NRAS-mutant melanoma cells.
»
10/17/23
Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience.
TMT group had higher percentage of local recurrence.
»
05/15/23
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
Novel αFAP TMs promising immunotheranostic tools.
»
12/15/23
< Prev
Next >